Screening hepcidin for mutations in juvenile hemochromatosis: identification of a new mutation (C70R)

被引:53
作者
Roetto, A
Daraio, F
Porporato, P
Caruso, R
Cox, TM
Cazzola, M
Gasparini, P
Piperno, A
Camaschella, C
机构
[1] Univ Turin, Dipartimento Sci Clin & Biol, Turin, Italy
[2] Osped Pediat Bambin Gesu, Div Ematol, Inst Ric & Cura Carattere Sci, Rome, Italy
[3] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England
[4] Policlin San Matteo, Dipartimento Med Interna & Oncol, IRCCS, I-27100 Pavia, Italy
[5] Univ Naples, Dipartimento Patol Gen 2, I-80138 Naples, Italy
[6] Telethon Inst Genet & Med, Naples, Italy
[7] Azienda Osped San Gerardo, Clin Med, Monza, Italy
关键词
D O I
10.1182/blood-2003-10-3390
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Juvenile or type 2 hemochromatosis (JH) is a genetic disease caused by increased intestinal iron absorption that leads to early massive iron overload. The main form of the disease is caused by mutations in a still unknown gene on chromosome 1q. Recently, we recognized a second type of JH with clinical features identical to the 1q-linked form, caused by mutations in the gene encoding hepcidin (HEPC). Hepcidin is a hepatic antimicrobial-like peptide whose role in iron homeostasis was first defined in animal models; deficiency of hepcidin in mice leads to iron overload, whereas its hepatic overexpression in transgenic animals causes iron deficiency. To define the prevalence of HEPC mutations in JH we screened the HEPC gene for mutation in 21 unrelated JH subjects. We identified a new mutation (C70R), which affects 1 of the 8 conserved cysteines that form the disulfide bonds and are critical for the stability of the polypeptide. (C) 2004 by The American Society of Hematology.
引用
收藏
页码:2407 / 2409
页数:3
相关论文
共 23 条
  • [1] Decreased liver hepcidin expression in the Hfe knockout mouse
    Ahmad, KA
    Ahmann, JR
    Migas, MC
    Waheed, A
    Britton, RS
    Bacon, BR
    Sly, WS
    Fleming, RE
    [J]. BLOOD CELLS MOLECULES AND DISEASES, 2002, 29 (03) : 361 - 366
  • [2] Identification of new mutations of the HFE, hepcidin, and transferrin receptor 2 genes by denaturing HPLC analysis of individuals with biochemical indications of iron overload
    Biasiotto, G
    Belloli, S
    Ruggeri, G
    Zanella, I
    Gerardi, G
    Corrado, M
    Gobbi, E
    Albertini, A
    Arosio, P
    [J]. CLINICAL CHEMISTRY, 2003, 49 (12) : 1981 - 1988
  • [3] Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis
    Bridle, KR
    Frazer, DM
    Wilkins, SJ
    Dixon, JL
    Purdie, DM
    Crawford, DHG
    Subramaniam, VN
    Powell, LW
    Anderson, GJ
    Ramm, GA
    [J]. LANCET, 2003, 361 (9358) : 669 - 673
  • [4] Juvenile hemochromatosis
    Camaschella, C
    Roetto, A
    De Gobbi, M
    [J]. SEMINARS IN HEMATOLOGY, 2002, 39 (04) : 242 - 248
  • [5] C/EBPα regulates hepatic transcription of hepcidin, an antimicrobial peptide and regulator of iron metabolism
    Courselaud, B
    Pigeon, C
    Inoue, Y
    Inoue, J
    Gonzalez, FJ
    Leroyer, P
    Gilot, D
    Boudjema, K
    Guguen-Guillouzo, C
    Brissott, P
    Loréal, O
    Ilyin, G
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (43) : 41163 - 41170
  • [6] Diagnosis of juvenile hemochromatosis in an 11-year-old child combining genetic analysis and non-invasive liver iron quantitation
    De Gobbi, M
    Caruso, R
    Daraio, F
    Chianale, F
    Pinto, RM
    Longo, F
    Piga, A
    Camaschella, C
    [J]. EUROPEAN JOURNAL OF PEDIATRICS, 2003, 162 (02) : 96 - 99
  • [7] Natural history of juvenile haemochromatosis
    De Gobbi, M
    Roetto, A
    Piperno, A
    Mariani, R
    Alberti, F
    Papanikolaou, G
    Politou, M
    Lockitch, G
    Girelli, D
    Fargion, S
    Cox, TM
    Gasparini, P
    Cazzola, M
    Camaschella, C
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2002, 117 (04) : 973 - 979
  • [8] Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation
    Ganz, T
    [J]. BLOOD, 2003, 102 (03) : 783 - 788
  • [9] Expression of hepcidin in hereditary hemochromatosis: evidence for a regulation in response to the serum transferrin saturation and to non-transferrin-bound iron
    Gehrke, SG
    Kulaksiz, H
    Herrmann, T
    Riedel, HD
    Bents, K
    Veltkamp, C
    Stremmel, W
    [J]. BLOOD, 2003, 102 (01) : 371 - 376
  • [10] The solution structure of human hepcidin, a peptide hormone with antimicrobial activity that is involved in iron uptake and hereditary hemochromatosis
    Hunter, HN
    Fulton, DB
    Ganz, T
    Vogel, HJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (40) : 37597 - 37603